Technical Analysis for ISR - IsoRay, Inc.

Grade Last Price % Change Price Change
F 1.01 -5.61% -0.06
ISR closed down 5.61 percent on Monday, April 12, 2021, on 23 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ISR trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -5.61%
Wide Bands Range Expansion -5.61%
Down 3 Days in a Row Weakness -5.61%
Oversold Stochastic Weakness -5.61%
Wide Bands Range Expansion -6.48%
Older End-of-Day Signals for ISR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington.
Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Cancer Treatment Of Cancer Oncology Breast Cancer Catheter Prostate Cancer Treatment Of Breast Cancer Radiation Melanoma Medical Products Colorectal Cancer Pancreatic Cancer Radiation Therapy Medical Physics Brain Cancer Balloon Catheter Liver Cancer Brachytherapy Ocular Melanoma Esophageal Cancer Pancreatic Cancers Treatment Of Prostate Cancer

Is ISR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.8
52 Week Low 0.35
Average Volume 8,040,969
200-Day Moving Average 0.86
50-Day Moving Average 1.36
20-Day Moving Average 1.18
10-Day Moving Average 1.09
Average True Range 0.11
ADX 18.87
+DI 16.74
-DI 27.78
Chandelier Exit (Long, 3 ATRs ) 1.15
Chandelier Exit (Short, 3 ATRs ) 1.34
Upper Bollinger Band 1.42
Lower Bollinger Band 0.94
Percent B (%b) 0.15
BandWidth 40.88
MACD Line -0.08
MACD Signal Line -0.07
MACD Histogram -0.0016
Fundamentals Value
Market Cap 88.1 Million
Num Shares 87.2 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -13.12
Price-to-Sales 3.45
Price-to-Book 8.46
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.15
Resistance 3 (R3) 1.16 1.12 1.12
Resistance 2 (R2) 1.12 1.09 1.12 1.11
Resistance 1 (R1) 1.07 1.07 1.05 1.06 1.11
Pivot Point 1.03 1.03 1.03 1.03 1.03
Support 1 (S1) 0.98 1.00 0.96 0.97 0.91
Support 2 (S2) 0.94 0.98 0.94 0.91
Support 3 (S3) 0.89 0.94 0.90
Support 4 (S4) 0.88